AMR Vocabulary
| Term | Definition |
|---|---|
| TB | Tuberculosis |
| TEAE | Treatment emergent adverse events |
| TLV | Tandvårds- och läkemedelsförmånsverket (Dental and Pharmaceutical Benefits Agency) |
| TOC | Test-of-cure |
| Triple I | (Impact Investment Initiative for Global Health): An initiative endorsed at the 2023 G7 Hiroshima Summit focused on connecting stakeholders and mobilizing private capital through impact investment. It aims to address critical global health issues—including the financial and developmental burdens of antimicrobial resistance (AMR)—by driving sustainable private and public financing, particularly in low- and middle-income countries (LMICs). |
| TRL | Technology Readiness Level, term and system developed to guide on a product or service’s go-to-market maturity |
| TRL-IS Framework | Technology Readiness Level - Implementation Science framework |
| TSS | Toxic Shock Syndrome |
| TTO | Technology Transfer Office, entity at university dedicated to bringing academic inventions to use by industry and society |
| TTP | Time to positivity |